Last Updated on September 22, 2020 by The Health Master
The Haryana State Industrial and Infrastructure Development Corporation (HSIIDC) is ready to bid for the central government announced bulk drug and medical device parks. it’s acquired 1000-acre land in Panipat for a proposed bulk drug park and is within the process of acquiring more land. The government is additionally proposing to line up a medical devices park in Karnal.
In the recently held webinar organised by the PHD Chamber of Commerce and Industry (PHDCCI) on “The way forward for Pharma Industry”, the authority informed that the proposed bulk drug park are going to be designed and equipped keeping all the industry requirements for simple doing business.
Anurag Aggarwal, MD, HSIIDC said that Haryana is right for fixing the pharma parks thanks to its strategic advantage as Haryana surrounds Delhi from three sides providing access to just about 11 per cent of the domestic market. it’s excellent road and air connectivity because 15 national highways are present in Haryana with four of them passing through the Delhi-NCR region and has international airports in its vicinity, at Delhi and Chandigarh.
However, he also raised concerns that the evaluation criteria of the majority drug parks seem to be favouring the coastline states. He said that the state has slipped from its ranking of simple doing business and can be losing the three points for coastal preference within the selection criteria. He stated, “We don’t understand why the coast has been given the advantage within the detailed guidelines of Bulk Drug Parks when only 11 states within the country have a coastline.” He said that in the Britishers’ time the ports wont to play a crucial role within the movement of products but now things isn’t an equivalent . And it’s something that can’t even be created. He said that the state is looking forward to a good evaluation within the selection criteria.
Also read: RPMA urge Govt to come up with pharma policy
N K Ahuja, Haryana State Drug Controller, Food and Drugs Administration, (FDA) Haryana highlighted the pharma policy of Haryana, which has been drafted in consultation with all stakeholders. He added that the regulatory policy of Haryana acts as a lover , philosopher and guide and its focus is to handhold and encourage entrepreneurs within the State.
Presenting the industry’s expectations, B R Sikri, vice chairman , Bulk Drugs Manufacturers Association of India stressed that transparency, simple doing business, location of all concerned offices within the park, single window system and deemed approval, competitive land cost etc., will go an extended way within the success of proposed parks in Haryana.
Mohit Jain, Chairman, Haryana State Chapter PHDCCI, appreciated the Haryana Government’s move to spice up the pharmaceutical sector within the State by launching a fanatical Haryana Pharmaceutical Policy 2019.
A K Singh, Principal Secretary, Industries and Commerce, Government of Haryana also informed that there’s an enormous scope for the pharma industry in Haryana because the State has a beautiful industrial policy, titled Enterprise Promotion Policy. He said that the policy will now lay stress on employment too. He said that for designing the majority drug park in Panipat it’s entered into an MoU with NIPER Mohali for fixing a search unit. it’s also getting to sign 10 more MoUs with the industry for research collaborations.
Responding to the query on the coastline, Navdeep Rinwa, Joint Secretary, Department of Pharmaceuticals, Government of India said that the majority Drug Parks scheme is on a challenge mode and therefore the marks to the coastline states isn’t only considered only from a dumping purpose but also from the very fact that massive capital is required for effluent treatment plants and compete with China when it’s playing the sport of volume. to form Indian industry competitive, the govt of India is giving preference to high scale and high-quality manufacturing.
He also informed that pharma is one among the ‘champion sectors’ identified by the govt of India to supply hand-holding to investors for improving manufacturing capabilities within the country. He said that the assembly Linked Incentive (PLI) schemes for promoting domestic manufacturing of KSMs, Dis, APIs and medical devices will go an extended way in boosting domestic manufacturing.
Informing that for the PLI scheme, the govt is receiving an honest response, he mentioned that it’s received a suggestion from the industry to extend the investment criteria of 1 of the merchandise categories that the minimum investment criteria was set at Rs 4000 crores.
The participants at the webinar also raised queries like; will protective tariff be placed on China on all government announced PLI scheme products to safeguard the industry, would the units within the bulk drugs parks be exempted from Environment Clearance etc.
The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.
